big day today and judging by the spike in sell-side volume going into the close we can expect more frenzied selling tomorrow ... lets hope our buying friend continues to play along also.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
